Onkológia 6/2010
Monoclonal antibodies in antitumorous therapy and infectious complications
Monoclonal antibodies are widely used in medical oncology in the concept of targeted biological treatment. Despite their therapeutical efficacy some of them are associated with adverse infectious events. This article is the review of infectious complications associated with the use of monoclonal antibodies in oncology.
Keywords: infectious complications, monoclonal antibodies, immunotherapy.
